ARCHIVES

The Antineoplaston Anomaly: How A Drug Was Used For Decades In Thousands Of Patients, With No Safety, Efficacy Data

This article is from The Cancer Letter archive.

Vol. 24 No. 36 | September 25, 1998

Download PDF Visit The Full Archive

Related Articles

Guest Editorial – Power Shifts to Communities

January 9, 1976

In Brief: Goldsmith Named CEO of CancerCare

April 11, 2014

Biomedical Supercomputer Will Be Available To NIH, Extramural Scientists; No Payback Planned To Starts

July 13, 1984

New Mexico Program Covers Entire State

January 21, 1977

In Brief: Senate Subcommittee Adds $100 Million For NCI Over House Bill, No Further Action Until Sept.

August 8, 1975

In Brief: Hawaii Center Searching For New Director: Rosenberg Denies Report He’s Going To Tampa

June 7, 1985